Class-Level Comparison
Growth Hormone vs Metabolic Peptides
How the growth hormone and metabolic peptide classes differ in mechanism, regulatory status, evidence depth, and the compounds that belong to each.
Educational content only. This page is compiled from published research for reference and is not medical advice, diagnosis, or treatment. Readers should verify claims against primary sources and consult a qualified healthcare provider before making any health decisions. Full disclaimer.
Growth Hormone
Growth hormone secretagogues and releasing peptides
Compounds in this class
Metabolic
Peptides studied for metabolic function and mitochondrial health
Compounds in this class
Class comparison at a glance
| Attribute | Growth Hormone | Metabolic |
|---|---|---|
| Compounds | 5 | 6 |
| Total studies indexed | 219 | 1,180 |
| Human studies | 74 | 518 |
| FDA approved | 2 | 3 |
| In clinical trials | 0 | 1 |
| Research-only | 1 | 2 |
| Category 2 banned | 2 | 0 |
| Average evidence level | L3.8 | L4 |
| Dominant mechanisms | ||
| Administration routes | oral, subcutaneous | intravenous, oral, subcutaneous, sublingual |
When each class is most relevant
Growth Hormone
Growth hormone secretagogues and releasing peptides
- Contains FDA-approved options with regulatory record
- Average evidence tier L3.8 across the class
- 2 compounds restricted from compounding (FDA Category 2)
Metabolic
Peptides studied for metabolic function and mitochondrial health
- Contains FDA-approved options with regulatory record
- Deep human clinical literature (518+ human studies)
- Average evidence tier L4 across the class
Frequently asked
What is the difference between growth hormone and metabolic peptides?
Growth Hormone peptides — growth hormone secretagogues and releasing peptides — most commonly act through ghrh receptor agonism or ghrelin receptor agonism. Metabolic peptides — peptides studied for metabolic function and mitochondrial health — most commonly act through glp-1 receptor agonism or dual gip/glp-1 agonism or ghrh receptor agonism. Beyond mechanism, the classes differ in FDA approval mix (2 approved in growth hormone vs 3 in metabolic) and in the depth of human clinical evidence available.
Which class has more FDA-approved compounds?
The growth hormone class currently includes 2 FDA-approved compound(s) out of 5 tracked. The metabolic class includes 3 FDA-approved compound(s) out of 6 tracked. FDA status matters because it governs legal availability through compounding pharmacies versus prescription-only dispensing.
Which class has more clinical research?
Growth Hormone compounds collectively account for 219 indexed studies, with 74 involving human subjects. Metabolic compounds account for 1,180 indexed studies, 518 human. More studies does not always mean stronger evidence — the quality and design of those studies matters more than raw count.
Can growth hormone and metabolic peptides be combined?
Combination protocols across these classes exist in clinical literature and integrative medicine practice, but most evidence for combination safety is weaker than for either class alone. Any stacking decision should involve a qualified clinician familiar with both classes' pharmacology, drug interactions, and overlapping adverse-event profiles.
How do I choose between growth hormone and metabolic?
The choice is driven by the therapeutic goal. Growth Hormone is most appropriate when growth hormone secretagogues and releasing peptides. Metabolic is most appropriate when studied for metabolic function and mitochondrial health. A qualified clinician can evaluate which class aligns best with your medical history, goals, and regulatory context.
Related class comparisons
Class hub
Growth Hormone →
Class hub
Metabolic →